Creative Planning Has $147,000 Holdings in Alignment Healthcare, Inc. (NASDAQ:ALHC)

Creative Planning increased its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 20.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,442 shares of the company’s stock after purchasing an additional 2,072 shares during the period. Creative Planning’s holdings in Alignment Healthcare were worth $147,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the stock. SG Americas Securities LLC bought a new position in Alignment Healthcare in the 3rd quarter worth approximately $521,000. Mackenzie Financial Corp raised its position in Alignment Healthcare by 110.0% in the 2nd quarter. Mackenzie Financial Corp now owns 36,526 shares of the company’s stock worth $286,000 after purchasing an additional 19,129 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in Alignment Healthcare by 20.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 55,531 shares of the company’s stock worth $434,000 after purchasing an additional 9,595 shares during the last quarter. Deerfield Management Company L.P. Series C raised its position in Alignment Healthcare by 31.8% in the 2nd quarter. Deerfield Management Company L.P. Series C now owns 10,901,485 shares of the company’s stock worth $85,250,000 after purchasing an additional 2,630,788 shares during the last quarter. Finally, AQR Capital Management LLC bought a new position in Alignment Healthcare in the 2nd quarter worth approximately $1,512,000. Institutional investors own 86.19% of the company’s stock.

Insider Buying and Selling

In related news, insider Dawn Christine Maroney sold 20,000 shares of the company’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $8.70, for a total value of $174,000.00. Following the completion of the transaction, the insider now directly owns 1,796,097 shares of the company’s stock, valued at approximately $15,626,043.90. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, insider Dawn Christine Maroney sold 20,000 shares of the stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $8.70, for a total transaction of $174,000.00. Following the completion of the transaction, the insider now directly owns 1,796,097 shares in the company, valued at $15,626,043.90. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Hakan Kardes sold 25,000 shares of the stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $11.48, for a total transaction of $287,000.00. Following the transaction, the insider now owns 380,444 shares of the company’s stock, valued at approximately $4,367,497.12. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 379,287 shares of company stock valued at $4,290,810. Company insiders own 6.60% of the company’s stock.

Alignment Healthcare Price Performance

Shares of ALHC stock opened at $13.46 on Tuesday. Alignment Healthcare, Inc. has a 12-month low of $4.46 and a 12-month high of $14.25. The firm has a market capitalization of $2.58 billion, a price-to-earnings ratio of -17.48 and a beta of 1.45. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The firm has a fifty day moving average of $11.36 and a 200-day moving average of $9.20.

Alignment Healthcare (NASDAQ:ALHC) last announced its earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.14). The firm had revenue of $692.43 million during the quarter, compared to analyst estimates of $662.11 million. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The company’s revenue for the quarter was up 51.6% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.19) EPS. On average, equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts recently weighed in on ALHC shares. Stifel Nicolaus boosted their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a “buy” rating in a research report on Friday, July 26th. Robert W. Baird upped their target price on shares of Alignment Healthcare from $10.00 to $11.00 and gave the company an “outperform” rating in a research report on Wednesday, August 14th. UBS Group upped their target price on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a research report on Wednesday, October 30th. Barclays upped their target price on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 30th. Finally, KeyCorp initiated coverage on shares of Alignment Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating for the company. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, six have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $10.33.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.